20
Participants
Start Date
February 12, 2025
Primary Completion Date
October 31, 2026
Study Completion Date
October 31, 2026
Leniolisib
Planned dose will range from 10 mg twice daily to 70 mg twice daily
RECRUITING
Mount Sinai Hospital, New York
NOT_YET_RECRUITING
National Institute of Health, Bethesda
RECRUITING
Texas Children's Hospital, Houston
RECRUITING
Children's Hospital Colorado, Aurora
RECRUITING
Lahey Hospital & Medical Center, Burlington
RECRUITING
IIS La Fe, Valencia
Lead Sponsor
Lahey Hospital & Medical Center
OTHER
Pharming Technologies B.V.
INDUSTRY